These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 9971797

  • 1. Suppressor mutations within the core binding factor (CBF/AML1) binding site of a T-cell lymphomagenic retrovirus.
    Martiney MJ, Levy LS, Lenz J.
    J Virol; 1999 Mar; 73(3):2143-52. PubMed ID: 9971797
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Second-site proviral enhancer alterations in lymphomas induced by enhancer mutants of SL3-3 murine leukemia virus: negative effect of nuclear factor 1 binding site.
    Ethelberg S, Hallberg B, Lovmand J, Schmidt J, Luz A, Grundström T, Pedersen FS.
    J Virol; 1997 Feb; 71(2):1196-206. PubMed ID: 8995642
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Transcriptional activation of a retrovirus enhancer by CBF (AML1) requires a second factor: evidence for cooperativity with c-Myb.
    Zaiman AL, Lenz J.
    J Virol; 1996 Aug; 70(8):5618-29. PubMed ID: 8764076
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Differences in activities of murine retroviral long terminal repeats in cytotoxic T lymphocytes and T-lymphoma cells.
    LoSardo JE, Cupelli LA, Short MK, Berman JW, Lenz J.
    J Virol; 1989 Mar; 63(3):1087-94. PubMed ID: 2644446
    [Abstract] [Full Text] [Related]

  • 14. Increased induction of osteopetrosis, but unaltered lymphomagenicity, by murine leukemia virus SL3-3 after mutation of a nuclear factor 1 site in the enhancer.
    Ethelberg S, Tzschaschel BD, Luz A, Diaz-Cano SJ, Pedersen FS, Schmidt J.
    J Virol; 1999 Dec; 73(12):10406-15. PubMed ID: 10559359
    [Abstract] [Full Text] [Related]

  • 15. Type B leukemogenic virus has a T-cell-specific enhancer that binds AML-1.
    Mertz JA, Mustafa F, Meyers S, Dudley JP.
    J Virol; 2001 Mar; 75(5):2174-84. PubMed ID: 11160721
    [Abstract] [Full Text] [Related]

  • 16. B-Cell lymphoma induction by akv murine leukemia viruses harboring one or both copies of the tandem repeat in the U3 enhancer.
    Lovmand J, Sorensen AB, Schmidt J, Ostergaard M, Luz A, Pedersen FS.
    J Virol; 1998 Jul; 72(7):5745-56. PubMed ID: 9621033
    [Abstract] [Full Text] [Related]

  • 17. Analysis of the significance of two single-base-pair differences in the SL3-3 and Akv virus long terminal repeats.
    Morrison HL, Dai HY, Pedersen FS, Lenz J.
    J Virol; 1991 Feb; 65(2):1019-22. PubMed ID: 1846181
    [Abstract] [Full Text] [Related]

  • 18. Identification of the SL3-3 virus enhancer core as a T-lymphoma cell-specific element.
    Boral AL, Okenquist SA, Lenz J.
    J Virol; 1989 Jan; 63(1):76-84. PubMed ID: 2535754
    [Abstract] [Full Text] [Related]

  • 19. PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2 beta/CBF beta proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells.
    Nuchprayoon I, Meyers S, Scott LM, Suzow J, Hiebert S, Friedman AD.
    Mol Cell Biol; 1994 Aug; 14(8):5558-68. PubMed ID: 8035830
    [Abstract] [Full Text] [Related]

  • 20. An SL3-3 murine leukemia virus enhancer variant more pathogenic than the wild type obtained by assisted molecular evolution in vivo.
    Ethelberg S, Sørensen AB, Schmidt J, Luz A, Pedersen FS.
    J Virol; 1997 Dec; 71(12):9796-9. PubMed ID: 9371648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.